Trial Profile
Assessment of Response of Patients on Surveillance for Favorable Risk Prostate Cancer to Dutasteride
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 09 Feb 2012 New trial record